Key Insights

The global mice models market, valued at $1.5 billion in 2025, is projected to experience robust growth, driven by a Compound Annual Growth Rate (CAGR) of 6.80% from 2025 to 2033. This expansion is fueled by several key factors. Firstly, the increasing prevalence of chronic diseases like cancer and cardiovascular disorders necessitates extensive preclinical research, significantly boosting demand for accurate and reliable animal models. Secondly, advancements in genetic engineering technologies, such as CRISPR/Cas9, enable the creation of highly specific and sophisticated mice models, further accelerating market growth. The rising adoption of contract research organizations (CROs) by pharmaceutical and biotechnology companies also contributes, as CROs frequently utilize mice models in their drug discovery and development processes. Finally, government funding initiatives focused on biomedical research provide sustained financial support for the sector, encouraging innovation and expansion within the mice models market. The market is segmented by mouse type (inbred, outbred, genetically engineered, hybrid/congenic), service (breeding, cryopreservation, model licensing, genetic testing), technology (CRISPR/Cas9, embryonic stem cell injection), and application (oncology, cardiovascular studies, neurology). North America currently holds a significant market share, owing to a strong presence of research institutions and pharmaceutical companies. However, Asia-Pacific is expected to witness substantial growth in the coming years, driven by rising healthcare expenditure and expanding research infrastructure in countries like China and India.

The competitive landscape is characterized by a mix of large multinational companies like Charles River Laboratories and Taconic Biosciences, alongside specialized smaller players focusing on specific niche technologies or services. Competition is fierce, driven by the need to offer advanced models, efficient services, and cost-effective solutions. Companies are increasingly investing in research and development to improve existing technologies and introduce innovative mice models tailored to specific research needs. The market faces some challenges, including stringent regulatory requirements for animal research, ethical considerations surrounding animal welfare, and the relatively high cost associated with creating and maintaining specialized mice models. Nevertheless, the overall outlook for the mice models market remains positive, driven by the continued importance of preclinical research in the drug discovery and development process and ongoing technological advancements within the field.

Mice Models Industry: A Comprehensive Market Report (2019-2033)

This comprehensive report provides an in-depth analysis of the Mice Models industry, covering market size, segmentation, growth drivers, challenges, and key players. The report utilizes data from the historical period (2019-2024), the base year (2025), and projects the market's trajectory through the forecast period (2025-2033). The study period encompasses the period 2019-2033, providing a holistic view of industry evolution. Expected market value in Millions USD are given throughout.

Mice Models Industry Market Concentration & Innovation

The global mice models market is characterized by a moderately concentrated landscape with a few dominant players capturing a significant market share. The market share of the top five companies is estimated at xx%, indicating room for smaller players to grow. Key players strategically engage in mergers and acquisitions (M&A) to expand their product portfolio, geographic reach, and technological capabilities. Significant M&A activity in the past five years has involved deals valued at an estimated xx Million. These consolidations have influenced market dynamics and intensified competition.

The industry is driven by continuous innovation in genetic engineering technologies, including CRISPR/Cas9, embryonic stem cell injection, and nuclear transfer. Regulatory frameworks, particularly concerning animal welfare and research ethics, play a crucial role in shaping industry practices. Product substitutes, such as in silico modeling and alternative cell-based assays, are gaining traction but have yet to significantly disrupt the mice models market. The demand for genetically engineered mice is largely driven by advances in biomedical research, specifically in oncology and neuroscience. End-user trends point towards a growing preference for complex, disease-specific models that better mimic human conditions. This is leading to increased demand for specialized services such as model in-licensing and custom model development.

• Market Concentration: Top 5 companies hold xx% market share (2025 estimate).
• M&A Activity: Estimated xx Million in deals (2019-2024).
• Key Innovation Drivers: CRISPR/Cas9, embryonic stem cell injection, nuclear transfer.
• Regulatory Influence: Significant impact on research and development practices.

Mice Models Industry Industry Trends & Insights

The global mice models market is experiencing robust growth, driven primarily by the escalating demand for preclinical drug discovery and development. The Compound Annual Growth Rate (CAGR) during the forecast period (2025-2033) is projected to be xx%. This growth is fueled by several key factors. Firstly, the rising prevalence of chronic diseases such as cancer and cardiovascular diseases globally has significantly increased the demand for effective and safe therapeutic interventions. This, in turn, necessitates extensive preclinical testing using animal models. Secondly, technological advancements, particularly in genetic engineering techniques like CRISPR-Cas9, allow for the creation of more sophisticated and accurate mouse models that more closely replicate human diseases and their complexities.

Technological advancements are reshaping the competitive landscape, providing opportunities for specialized service providers to emerge. For example, the rise of CRISPR technology has lowered the barrier for entry for some players in the genetic engineering mice segment. This, combined with growing consumer preferences for more precise and efficient models, necessitates continuous innovation and investment in technological capabilities. The growing demand for personalized medicine and growing understanding of the complexities of human disease is increasing the reliance on more sophisticated and disease-specific mouse models. This increased sophistication demands more specialized services, driving revenue growth in niche areas.

• CAGR (2025-2033): xx%
• Market Penetration: Growing in oncology, neurology, and cardiovascular research.
• Competitive Dynamics: Increasing competition among providers of specialized services.

Dominant Markets & Segments in Mice Models Industry

The North American region, particularly the United States, currently dominates the global mice models market, driven by a large and well-funded research and development sector. This dominance is attributed to several factors including a robust regulatory framework, high levels of investment in biotechnology and pharmaceutical research and a concentration of leading academic institutions and pharmaceutical companies.

• Leading Region: North America (United States).
• Key Drivers (North America): Robust R&D investment, established regulatory frameworks, high concentration of pharmaceutical and biotech companies.

Segment Dominance Analysis:

• Type: Genetically engineered mice represent the fastest-growing segment due to advancements in genetic engineering technologies. The high demand for these models in preclinical drug discovery and development contributes significantly to market growth.
• Service: Breeding and genetic testing services account for a significant share of the market, driven by the increasing demand for tailored mouse models that meet specific research needs.
• Technology: CRISPR/Cas9 technology is rapidly gaining market share due to its precision and cost-effectiveness compared to other technologies. The popularity of this method is driving growth in this technology segment.
• Application: Oncology remains the largest application segment, driven by the high prevalence of cancer and the urgent need for novel therapeutic interventions.

Further detailed analysis on the dominance of each segment can be found within the full report.

Mice Models Industry Product Developments

Recent product innovations in the mice models industry include the development of more sophisticated genetically modified mice featuring specific human disease mutations. These models help achieve a higher degree of accuracy in preclinical studies. These advancements, coupled with improved breeding and cryopreservation techniques, enhance the efficiency and effectiveness of research. Companies are also focusing on developing new technologies and improving existing ones to create more refined models. The market fit for these innovations is strong, fueled by the increasing complexity of biomedical research. Moreover, the use of AI and machine learning is starting to augment the analysis of data from mouse models.

Report Scope & Segmentation Analysis

This report provides a detailed analysis of the mice models market, segmented by:

• Type: Inbred Mice, Outbred Mice, Genetically Engineered Mice, Hybrid/Congenic Mice, Other Types. Each segment shows varying growth rates, reflecting the changing needs of the research community. Genetically engineered mice command the highest market share and fastest growth rate.

• Service: Breeding, Cryopreservation, Model in-Licensing, Genetic Testing, Other Services. Breeding and genetic testing are currently the largest segments, although model in-licensing is experiencing rapid expansion.

• Technology: CRISPR/CAS, Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies. CRISPR/Cas9 is the most rapidly growing technology.

• Application: Oncology, Cardiovascular Studies, Neurology, Other Applications. Oncology consistently dominates, while neurology and cardiovascular studies are showing strong growth projections.

Growth projections, market sizes, and competitive dynamics are analyzed for each segment within the full report.

Key Drivers of Mice Models Industry Growth

The growth of the mice models industry is primarily fueled by several key factors:

• Technological Advancements: Innovative genetic engineering techniques (CRISPR/Cas9) enable the creation of more accurate and complex disease models.
• Increased Demand for Preclinical Research: The growing prevalence of chronic diseases drives the need for robust preclinical testing.
• Government Funding & Regulatory Support: Increased investment in biomedical research from governmental bodies significantly boosts the market.

Challenges in the Mice Models Industry Sector

The mice models industry faces several challenges:

• Regulatory Hurdles: Stringent regulations governing animal research increase development costs and timelines.
• Supply Chain Issues: Ensuring consistent supply of healthy and genetically-consistent mice can be challenging.
• High Costs: Developing and maintaining complex mouse models is expensive, potentially limiting accessibility for smaller research groups.

Emerging Opportunities in Mice Models Industry

Several emerging opportunities exist in the mice models industry:

• Development of Humanized Mouse Models: These models offer greater translational relevance to human diseases.
• Integration of AI/Machine Learning: Leveraging these technologies to analyze data from mouse studies.
• Expansion into Emerging Markets: Growing demand from developing economies presents untapped potential.

Leading Players in the Mice Models Industry Market

• Ozgene Pty Ltd
• The Jackson Laboratory
• Janvier Labs
• The Andersons Inc
• Trans Genic Inc
• Ingenious Targeting Laboratory
• ENVIGO
• Charles River Laboratories International Inc
• Taconic Biosciences Inc
• Genoway
• Horizon Discovery Group PLC (Sage Labs Inc)
• Allentown LLC
• Harbour Biomed
• PolyGene

Key Developments in Mice Models Industry Industry

• November 2023: Scientists at the UCI MODEL-AD group developed the Trem2R47H NSS mouse model for Alzheimer's disease research.
• February 2024: University of Texas Southwestern Medical Center introduced a new compound extending survival in an ALS mouse model.

Strategic Outlook for Mice Models Industry Market

The mice models market is poised for sustained growth, driven by ongoing technological advancements, increasing demand for preclinical research, and expanding applications in various therapeutic areas. The continued development of more sophisticated and human-relevant models, coupled with the adoption of advanced analytical techniques, will enhance the market's future potential and contribute to significant advancements in biomedical research.

Mice Models Industry Segmentation

• 1. Type
  • 1.1. Inbred Mice
  • 1.2. Outbred Mice
  • 1.3. Genetically Engineered Mice
  • 1.4. Hybrid/Congenic Mice
  • 1.5. Other Types
• 2. Service
  • 2.1. Breeding
  • 2.2. Cryopreservation
  • 2.3. Model in-Licensing
  • 2.4. Genetic Testing
  • 2.5. Other Services
• 3. Technology
  • 3.1. CRISPR/CAS9
  • 3.2. Embryonic Stem Cell Injection
  • 3.3. Nuclear Transfer
  • 3.4. Other Technologies
• 4. Application
  • 4.1. Oncology
  • 4.2. Cardiovascular Studies
  • 4.3. Neurology
  • 4.4. Other Applications

Mice Models Industry Segmentation By Geography

• 1. North America
  • 1.1. United States
  • 1.2. Canada
  • 1.3. Mexico
• 2. Europe
  • 2.1. Germany
  • 2.2. United Kingdom
  • 2.3. France
  • 2.4. Italy
  • 2.5. Spain
  • 2.6. Rest of Europe
• 3. Asia Pacific
  • 3.1. China
  • 3.2. Japan
  • 3.3. India
  • 3.4. Australia
  • 3.5. South Korea
  • 3.6. Rest of Asia Pacific
• 4. Middle East and Africa
  • 4.1. GCC
  • 4.2. South Africa
  • 4.3. Rest of Middle East and Africa
• 5. South America
  • 5.1. Brazil
  • 5.2. Argentina
  • 5.3. Rest of South America